Literature DB >> 6608234

Quantitative evaluation of fatty liver by computed tomography in rabbits.

R Kawata, K Sakata, T Kunieda, S Saji, H Doi, Y Nozawa.   

Abstract

Biochemical, histologic, and computed tomographic (CT) examinations of the liver were performed in 32 rabbits in which fatty liver was induced by prolonged intravenous fat infusion. In two groups of rabbits, in which 2 and 4 g/kg/day of fat emulsion was administered, respectively, posttreatment reduction in CT value of mild degree was observed, but the reduction was insignificant from the standpoint of diagnosis from CT images. In the group that received 8 g/kg/day of fat emulsion, posttreatment change in CT value was -14.9 +/- 5.1 H, a sufficient reduction for a diagnosis of fatty liver of moderate degree. No significant change in CT value was seen in the no-treatment group or in the group in which 80 ml/kg/day of normal saline solution was infused for 4 weeks. Reduction in CT value in fatty liver might be due largely to accumulation of triglyceride and cholesterol in the liver cells. Significant correlation was found between changes in CT value of the liver and degrees of histologic fat accumulation in the liver cells. Consecutive measurement of CT values of the liver during prolonged intravenous hyperalimentation is a nonaggressive method of diagnosing fatty liver.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608234     DOI: 10.2214/ajr.142.4.741

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Andrew Paul DeFilippis; Michael J Blaha; Seth S Martin; Robert M Reed; Steven R Jones; Khurram Nasir; Roger S Blumenthal; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2013-01-29       Impact factor: 5.162

2.  Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis).

Authors:  Geoffrey H Tison; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Moyses Szklo; Jingzhong Ding; Matthew J Budoff
Journal:  Am J Cardiol       Date:  2015-05-21       Impact factor: 2.778

3.  Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge.

Authors:  Lucia Pacifico; Eleonora Poggiogalle; Vito Cantisani; Guendalina Menichini; Paolo Ricci; Flavia Ferraro; Claudio Chiesa
Journal:  World J Hepatol       Date:  2010-07-27

4.  Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis.

Authors:  Irfan Zeb; Dong Li; Khurram Nasir; Ronit Katz; Vahid N Larijani; Matthew J Budoff
Journal:  Acad Radiol       Date:  2012-04-21       Impact factor: 3.173

5.  Non-invasive means of measuring hepatic fat content.

Authors:  Sanjeev-R Mehta; E-Louise Thomas; Jimmy-D Bell; Desmond-G Johnston; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

6.  "Skip areas" in hepatic steatosis: a sonographic-angiographic study.

Authors:  G Marchal; E Tshibwabwa-Tumba; E Verbeken; W Van Roost; W Van Steenbergen; A Baert; J Lauwerijns
Journal:  Gastrointest Radiol       Date:  1986

7.  YKL-40 is a Protective Biomarker for Fatty Liver in World Trade Center Particulate Matter-Exposed Firefighters.

Authors:  Soo Jung Cho; Ghislaine C Echevarria; Young Im Lee; Sophia Kwon; Kwan Yong Park; Jun Tsukiji; William N Rom; David J Prezant; Anna Nolan; Michael D Weiden
Journal:  J Mol Biomark Diagn       Date:  2014

8.  Sonographic Evaluation of Liver Hemodynamic Indices in Overweight and Obese Dogs.

Authors:  A F Belotta; C R Teixeira; C R Padovani; S C Rahal; M N Mayer; M J Mamprim
Journal:  J Vet Intern Med       Date:  2017-12-27       Impact factor: 3.333

9.  Investigation of comorbidities of COVID-19 patients with hepatosteatosis using latent class analysis.

Authors:  Ozge Pasin; Sirin Cetin; Ahmet Turan Kaya
Journal:  Front Public Health       Date:  2022-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.